GlobeNewswire·Nov 7, 2025, 4:05 PM ET

Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights

RKDA

Arcadia Biosciences reported year-to-date Zola coconut water revenues increased 26% compared to the prior year.
Arcadia achieved gross profit margins exceeding 30% for the 11th consecutive quarter.
The company's cash balance declined by $257,000 to end the quarter at $1.1 million.
Third-quarter 2025 total revenues were $1.302 million, a 15% decrease from $1.537 million in the same period of 2024.
First nine months of 2025 total revenues rose 3% to $3.957 million, driven entirely by Zola coconut water sales.
Zola revenues grew 26% year-over-year for the first nine months of 2025, offsetting $700,000 in GLA oil sales from 2024 that did not occur in 2025.
SG&A expenses reached an all-time low, decreasing by $671,000 in the third quarter and $1.6 million for the first nine months of 2025.
Arcadia owns 2.7 million shares of Above Food Ingredients Inc. stock, representing partial repayment of a $6 million note receivable from the GoodWheat asset sale.
A $4.7 million credit loss was recognized regarding the remaining balance of the Above Food note receivable due to non-payment of principal 1 interest.
Net income attributable to common stockholders was $856,000 ($0.63 per share) for the third quarter, compared to a $1.6 million loss in the prior year.
Net loss for the first nine months of 2025 was $1.0 million ($0.73 per share), an improvement from the $3.0 million loss in the same period of 2024.
The pending business combination with Roosevelt Resources remains in progress, with timing uncertainty due to the ongoing federal government shutdown.
No conference call will be held to discuss third-quarter results because of the ongoing transaction with Roosevelt Resources.